Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 84,223Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Orfadin

PharmaCompass

01

Brand Name : Orfadin

Nitisinone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Orfadin

arrow
2024 ACI Convention
Not Confirmed

Nitisinone

Main Therapeutic Indication : Genetic Disorders

Currency : USD

2021 Revenue in Millions : 49

2020 Revenue in Millions : 73

Growth (%) : -31

blank

02

Brand Name : Orfadin

Nitisinone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Orfadin

arrow
2024 ACI Convention
Not Confirmed

Nitisinone

Main Therapeutic Indication : Genetic Diseases

Currency : USD

2022 Revenue in Millions : 44

2021 Revenue in Millions : 49

Growth (%) : -12

blank

03

Brand Name : Orfadin

Nitisinone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Orfadin

arrow
2024 ACI Convention
Not Confirmed

Nitisinone

Main Therapeutic Indication : Genetic Diseases

Currency : USD

2023 Revenue in Millions : 43

2022 Revenue in Millions : 44

Growth (%) : -2

blank